DXP-106 in Solid Tumor Patients.
DXP-106 in Solid Tumor Patients.
Recruiting · NCT07532018 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DXP-106 in Solid Tumor Patients. | cancer, neoplasm | Recruiting | Phase 1 | 2026-09-15 | NCT07532018 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Singlomics Biopharmaceuticals Zhuhai Co., Ltd. | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University | Hangzhou | China | 1 |
| The First Hospital of Shanxi Medical University | Taiyuan | China | 9 |
| Zhongshan Hospital, Fudan University | Shanghai | China | 86 |